An Assessment of Medical Resource Utilization and Hospitalization Cost Associated with a Diagnosis of Anemia in Women with Obstetrical Bleeding in the United States

2008 ◽  
Vol 17 (8) ◽  
pp. 1279-1284 ◽  
Author(s):  
Andra H. James ◽  
Snehal T. Patel ◽  
Wendy Watson ◽  
Qasim R. Zaidi ◽  
Antoinette Mangione ◽  
...  
Keyword(s):  
United States ◽  
Resource Utilization ◽  
The United States ◽  
Medical Resource ◽  
Hospitalization Cost ◽  
Medical Resource Utilization

scholarly journals PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES

2011 ◽  
Vol 14 (3) ◽  
pp. A50
Author(s):  
C. Korves ◽  
A. Eldar-Lissai ◽  
D. Rodermund ◽  
E. Swallow ◽  
A.K. Cummings ◽  
...  
Keyword(s):  
United States ◽  
Heart Failure ◽  
Chronic Heart Failure ◽  
Resource Utilization ◽  
The United States ◽  
Medical Resource ◽  
Medical Resource Utilization

Generic antiepileptic drugs and associated medical resource utilization in the United States

Neurology ◽  
2010 ◽  
Vol 74 (20) ◽  
pp. 1566-1574 ◽  
Author(s):  
D. M. Labiner ◽  
P. E. Paradis ◽  
R. Manjunath ◽  
M. S. Duh ◽  
M. H. Lafeuille ◽  
...  
Keyword(s):  
United States ◽  
Antiepileptic Drugs ◽  
Resource Utilization ◽  
The United States ◽  
Medical Resource ◽  
Medical Resource Utilization

Abstract P2: Medical Resource Utilization and Costs Following Hospitalization of Patients with Chronic Heart Failure in the United States

2011 ◽  
Vol 4 (suppl_2) ◽  
Author(s):  
Caroline Korves ◽  
Adi Eldar-Lissai ◽  
Doug Rodermund ◽  
Elyse Swallow ◽  
Alice Kate Cummings ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Sick Leave ◽  
Resource Utilization ◽  
Indirect Costs ◽  
The United States ◽  
Data Availability ◽  
Index Hospitalization ◽  
Medical Resource ◽  
Medical Resource Utilization

Background: The study objective was to determine medical resource utilization and direct and indirect costs following hospitalization with chronic heart failure (HF). Methods: Patients (Pts) with ≥1 hospitalization with a chronic HF claim (ICD-9 428.22, 428.32 or 428.42) were identified in a US commercial insurance claims database from 2004-2008. Pts were observed from beginning of first hospitalization (index hospitalization) for chronic HF until disenrollment or end of data availability. Inpatient, outpatient, and prescription drug data were used to estimate per patient per month (PPPM) utilization rates. Costs (2009 USD) were calculated per hospitalization and PPPM for patients ≤65 years, and included insurers’ reimbursement, patient out-of-pocket (OOP) and sick leave. Results: There were 7,814 pts (mean age 73.2 years, 55.7% (4,355/7,814) male) meeting inclusion criteria. Mean HF hospitalization length of stay increased from 6.7 days at index hospitalization to 8.2 days at fourth re-hospitalization. Rate of HF-related re-hospitalization remained over 0.045 PPPM throughout 24 months of follow-up, accounting for the majority of all-cause hospitalizations. Rate of all-cause and HF-related outpatient visits peaked at 4.0 and 0.59 visits PPPM, respectively, within the three months after index hospitalization. Index hospitalization was most expensive (Table). Patient OOP costs accounted for less than 10% of direct costs (Table) and sick leave costs were less than $1,800 at any hospitalization. During the study period, outpatient cardiovascular drugs accounted for a small proportion of total pharmacy costs; average PPPM cost varied from $88 to $124, less than 1% of the average cost of a HF-related hospitalization. Conclusions: Treating chronic HF pts is resource intensive. The greatest burden occurs within the three months after index hospitalization and pts continue to be burdened after hospitalization by high inpatient and outpatient visit rates. Index hospitalization HF-related re-hospitalization 1st 2nd 3rd 4th Total direct medical costs $31,998 $22,047 $23,946 $24,839 $24,517 Reimbursement by insurers $31,023 $21,521 $23,103 $23,781 $23,971 Patient out-of-pocket $975 $526 $843 $1,058 $546 Indirect costs (sick leave) $1,194 $1,194 $1,281 $1,703 $1,764 Total $33,192 $23,241 $25,227 $26,542 $26,281

Impact of Anemia on Medical Resource Utilization and Hospitalization Cost in Women with Obstetrical Bleeding.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 5168-5168 ◽  
Author(s):  
Andra James ◽  
Snehal Patel ◽  
Quinn Dinh
Keyword(s):  
Blood Transfusion ◽  
Resource Utilization ◽  
Burden Of Illness ◽  
Demographic Characteristics ◽  
Medical Resource ◽  
Hospitalization Cost ◽  
Diagnosis Codes ◽  
Medical Resource Utilization ◽  
Increased Risk ◽  
The U.S

Abstract Objective: Anemia during pregnancy has been associated with adverse maternal and fetal outcomes. Although women with obstetrical bleeding are at increased risk for developing anemia, little is known about the prevalence and burden associated with anemia in hospitalized women with this condition. This study was conducted to estimate the prevalence, demographic characteristics, medical resource utilization, and hospitalization cost associated with anemia in hospitalized women with obstetrical bleeding in the U.S. Methods: The Healthcare Cost and Utilization Project Nationwide Inpatient Sample (2003) was queried using ICD-9-CM codes to identify all pregnancy-related discharges as well as discharges with diagnosis codes for conditions associated with obstetrical bleeding. Descriptive statistics were used to evaluate demographic characteristics, medical resource utilization components, and hospitalization cost for two groups: cases with anemia and cases without anemia. Results: Of the estimated 4,525,714 pregnancy-related discharges in the U.S. in 2003, more than 250,000 recorded diagnosis codes associated with obstetrical bleeding. Nearly 1 in 5 of these women had an anemia diagnosis. A diagnosis of anemia in hospitalized women with obstetrical bleeding was associated with a 9-fold increase in blood transfusion (p<.0001), 33% longer average length of stay (p<.0001), and 50% higher mean cost per hospitalization (p<.0001). Conclusions: Anemia and blood transfusion are frequently observed in hospitalized women with obstetrical bleeding. To improve outcomes in these patients and alleviate the adverse impact of anemia on postpartum health status, greater provider awareness of the prevalence and burden of illness associated with anemia in hospitalized women with obstetrical bleeding is warranted.

Sign in / Sign up

Export Citation Format

Share Document